Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Way Wua Wong
Observed names:
Way W. Wong,
Wong, Way,
Wong, Way Wua
Institution:
University of Auckland
Observed institution:
University of Auckland
ORCID:
0000-0002-2300-0930
Observed ORCID:
0000-0002-2300-0930
OpenAlex ID:
A5113289545
Next-Generation Hypoxic Cell Radiosensitizers: Nitroimidazole Alkylsulfonamides
2017
·
Muriel Bonnet
, Cho Rong Hong
, et al.
·
Journal of Medicinal Chemistry
·
75
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
2018
·
Stephen M.F. Jamieson
, Peter Tsai
, et al.
·
JCI Insight
·
61
PDF
Radiosensitization of head and neck squamous cell carcinoma lines by DNA-PK inhibitors is more effective than PARP-1 inhibition and is enhanced by SLFN11 and hypoxia
2019
·
Tet Woo Lee
, Way Wua Wong
, et al.
·
International Journal of Radiation Biology
·
49
Hypoxia-selective radiosensitisation by SN38023, a bioreductive prodrug of DNA-dependent protein kinase inhibitor IC87361
2019
·
Way Wua Wong
, Rosanna K. Jackson
, et al.
·
Biochemical Pharmacology
·
28
Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors
2019
·
Benjamin D. Dickson
, Way Wua Wong
, et al.
·
Molecules
·
23
PDF
Radiosensitisation of SCCVII tumours and normal tissues in mice by the DNA-dependent protein kinase inhibitor AZD7648
2021
·
Cho R. Hong
, Chantal D. Buckley
, et al.
·
Radiotherapy and Oncology
·
22
Hypoxia‐Activated Prodrugs of PERK Inhibitors
2019
·
Lydia P. Liew
, Dean C. Singleton
, et al.
·
Chemistry - An Asian Journal
·
15
Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers
2024
·
Cho R. Hong
, Lydia P. Liew
, et al.
·
Journal of Medicinal Chemistry
·
6
Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
2023
·
Stephen M.F. Jamieson
, Peter Tsai
, et al.
·
JCI Insight
·
6
PDF
Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation
2023
·
Way W. Wong
, Sophia F. O'Brien-Gortner
, et al.
·
RSC Medicinal Chemistry
·
4
PDF
Benzotriazine Di-Oxide Prodrugs for Exploiting Hypoxia and Low Extracellular pH in Tumors
2019
·
Michael P. Hay
, Hong Nam Shin
, et al.
·
Molecules
·
4
PDF
Systemic CYP3A inhibition by ritonavir enables selective targeting of hypoxic tumour cells by prodrugs of DNA-PK inhibitors
2026
·
Cho Rong Hong
, Benjamin D. Dickson
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract PO-018: Hypoxia activated prodrugs of DNA-dependent protein kinase inhibitors as radiosensitisers of head and neck squamous cell carcinomas
2021
·
Michael P. Hay
, Way W. Wong
, et al.
·
Clinical Cancer Research
·
1
Abstract A001: Discovery of imidazo [4,5-c]pyridin-2-ones as selective inhibitors of DNA-dependent protein kinase and effective radiosensitizers
2024
·
Michael P. Hay
, Cho R. Hong
, et al.
·
Cancer Research
Abstract A004: Targeting tumor hypoxia with prodrugs of DNA-dependent protein kinase inhibitors
2024
·
Lydia P. Liew
, Cho R. Hong
, et al.
·
Cancer Research
Abstract 169: Preclinical efficacy and sensitivity determinants of evofosfamide in molecularly defined models of head and neck squamous cell carcinoma
2017
·
Francis W. Hunter
, Avik Shome
, et al.
·
Cancer Research
Subversion of cellular autophagy by rotavirus
2013
·
Way W. Wong
·
ResearchSpace (University of Auckland)
Show more works
View as search
Works count:
19
Citation count:
295
H-index:
7
I10-index:
7
Year
Topic
Type